cass commercial - CASS
CASS
Close Chg Chg %
46.79 -0.03 -0.06%
Closed Market
46.76
-0.03 (0.06%)
Volume: 72.83K
Last Updated:
Feb 6, 2026, 4:00 PM EDT
Company Overview: cass commercial - CASS
CASS Key Data
| Open $46.94 | Day Range 46.50 - 47.23 |
| 52 Week Range 36.07 - 47.23 | Market Cap $606.06M |
| Shares Outstanding 13.08M | Public Float 11.51M |
| Beta 0.46 | Rev. Per Employee N/A |
| P/E Ratio 17.93 | EPS $2.66 |
| Yield 267.15% | Dividend $0.32 |
| EX-DIVIDEND DATE Mar 3, 2026 | SHORT INTEREST N/A |
| AVERAGE VOLUME 81.29K |
CASS Performance
| 1 Week | 4.00% | ||
| 1 Month | 12.57% | ||
| 3 Months | 18.23% | ||
| 1 Year | 8.62% | ||
| 5 Years | 10.28% |
CASS Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
1
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 45.00 | |
| Number of Ratings | 1 | Current Quarters Estimate | 0.62 | |
| FY Report Date | 03 / 2026 | Current Year's Estimate | 2.81 | |
| Last Quarter’s Earnings | 0.68 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 2.46 | Next Fiscal Year Estimate | 3.50 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 1 | 1 | 1 | 1 |
| Mean Estimate | 0.62 | 0.67 | 2.81 | 3.50 |
| High Estimates | 0.62 | 0.67 | 2.81 | 3.50 |
| Low Estimate | 0.62 | 0.67 | 2.81 | 3.50 |
| Coefficient of Variance | N/A | N/A | N/A | N/A |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 0 | 0 | 0 |
| OVERWEIGHT | 1 | 1 | 1 |
| HOLD | 0 | 0 | 0 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Cass Commercial - CASS
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Cass Commercial - CASS
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Jan 30, 2026 | Matt S. Schuckman Executive Vice President | 12,958 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $44.25 per share | 573,391.50 |
| Jan 30, 2026 | Eric H. Brunngraber Executive Chairman; Director | 165,724 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $44.25 per share | 7,333,287.00 |
| Jan 30, 2026 | Eric H. Brunngraber Executive Chairman; Director | 173,938 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jan 30, 2026 | Eric H. Brunngraber Executive Chairman; Director | 170,062 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $44.25 per share | 7,525,243.50 |
| Jan 30, 2026 | Matt S. Schuckman Executive Vice President | 13,467 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jan 30, 2026 | Michael J. Normile CFO | 17,835 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $44.25 per share | 789,198.75 |
| Jan 30, 2026 | Michael J. Normile CFO | 19,621 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jan 30, 2026 | Michael J. Normile CFO | 18,784 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $44.25 per share | 831,192.00 |
| Jan 30, 2026 | Matt S. Schuckman Executive Vice President | 11,983 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $44.25 per share | 530,247.75 |
| Jan 30, 2026 | Dwight D. Erdbruegger President | 21,833 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $44.25 per share | 966,110.25 |
| Jan 30, 2026 | Dwight D. Erdbruegger President | 23,580 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jan 30, 2026 | Dwight D. Erdbruegger President | 22,945 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $44.25 per share | 1,015,316.25 |
| Jan 29, 2026 | Martin H. Resch President & CEO | 52,379 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jan 29, 2026 | Martin H. Resch President & CEO | 48,353 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $44.25 per share | 2,139,620.25 |
| Jan 29, 2026 | James M. Cavellier CIO | 21,160 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $44.25 per share | 936,330.00 |
| Jan 29, 2026 | James M. Cavellier CIO | 21,761 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jan 29, 2026 | James M. Cavellier CIO | 20,086 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $44.25 per share | 888,805.50 |
| Jan 29, 2026 | Martin H. Resch President & CEO | 50,687 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $44.25 per share | 2,242,899.75 |
| Apr 18, 2025 | Randall L. Schilling Director | 30,477 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $39.48 per share | 1,203,231.96 |
| Apr 18, 2025 | Joseph D. Rupp Director | 20,808 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $39.48 per share | 821,499.84 |